How Do You Get Experienced Urologists to Engage in the New Norm For Prostate Cancer? February 15, 2020 Listen to how Dr. Jason Hafron from the Michigan Institute of Urology, found his passion for Urologic care at a young age and how he has since become an infl... Continue Reading
When You Bring in a Partner, It’s the Unknown February 15, 2020 Is your practice considering an acquisition? Listen along as Dr. Mike Gambla from Central Ohio Urology Group shares his experience with private equity acquis... Continue Reading
If We Focus on Taking Care of The Patient, Everything Else Will Take Care of Itself February 15, 2020 E. Scot Davis, CEO of Arkansas Urology talks through his experience creating men’s health clinics and advanced treatment pathways to improve the competitiv... Continue Reading
Now We Can Look at Patients and Help Determine If They Need Treatment at All February 15, 2020 Listen to Dr. Jonathan Henderson, CEO of Regional Urology Shreveport Louisiana as he discusses his experience with being an early adopter of hereditary cance... Continue Reading
Genetics Is Impacting Every Aspect of Healthcare Now February 15, 2020 Sarah Nielsen, a genetic counselor from the University of Chicago, discusses the importance of educating physicians about how genetics and family history imp... Continue Reading
Gleason Grading Is Good to an Extent… February 15, 2020 Dr. Todd Cohen, VP of Medical Affairs at Myriad Genetics and Dr. Mark Edney, Medical Director at Peninsula Institute for Laparoscopic and Robotic Surgery dis... Continue Reading
I Could Talk About the Clinical Stuff, but I Needed to Know the Business Behind It February 11, 2020 Dr. Angelo Baccala, Division Chief of Urology at Lehigh Valley Hospital Network discusses the operational roadblocks he encountered in supporting his busines... Continue Reading
“I Am So Thankful That We Have This Technology” August 6, 2019 Ed Hoppe received genetic testing after his prostate cancer diagnosis because of his extensive family history of cancer. The Myriad myRisk Hereditar... Continue Reading
“I Did Get This Gene Mutation from My Dad” July 2, 2019 Ed Hoppe is a patient with prostate cancer who received genetic testing with the Myriad myRisk Hereditary Cancer test. From this test, he discove... Continue Reading
“Gene Mutations Don’t Discriminate Between Men and Women” June 4, 2019 Recently we shared a story about Ed Hoppe and his prostate cancer. After Ed’s diagnosis, he received genetic testing and learned about a mutation in ... Continue Reading
2019 Prostate Cancer Statistics April 17, 2019 Prostate cancer is one of the most common cancers in American men, and this is made apparent by the statistics surrounding it. It is estimated by the American C... Continue Reading
“It Had Affected My Family As Much As It Had Affected Just Me.” March 14, 2019 After going to a routine checkup in the spring of 2017, Ed Hoppe was told that his PSA level was elevated and was referred to a local urologist, Dr. Goodso... Continue Reading
“I Don’t Know Where I’d Be Today Had I Not Tested With Prolaris” November 2, 2018 Follow Al on his journey through his prostate cancer diagnosis, the choices he made, and how this experience has shaped his life. Learn about how th... Continue Reading
“Prolaris Took the Weight of the World Off Our Shoulders” November 2, 2018 Accompany Camie Piazza as she stands alongside her husband who was diagnosed with prostate cancer. Learn how the Prolaris test results can guide a patie... Continue Reading
Applying Prolaris Data to an Evidentiary Framework February 15, 2018 Learn more about how the Prolaris® prostate cancer (PCa) prognostic test aligns with the widely cited and accepted Simon et al. evidentiary framework of 2009,... Continue Reading